In Neural Imaging, Dr. Parra is collaborating with Memorial-Sloan Kettering Cancer Center to develop tools for the analysis of Magnetic Resonance Spectroscopic Imaging (MRSI). The goal is to identify markers of metabolic function that are indicative of brain tumors. Dr Bikson is concurrently developing technology to facilitate drug delivery to the brain, including for the treatment of identified tumors. Dr. Bikson is developing devices for Electrochemotherapy and drug delivery as well as intra-operative assist tools.

Leave a reply

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong> 

required